Skip to main content
Clinical Trials/NCT03060876
NCT03060876
Recruiting
N/A

Prospective Register Study of Patients After Proximal Humerus and Humerus Shaft Fracture for Data Collection of Healing Process, Quality of Life and Shoulder Function According to the Treatment Method - Hanover Humerus Register (HHR)

Hannover Medical School1 site in 1 country1,000 target enrollmentJune 2016

Overview

Phase
N/A
Intervention
Not specified
Conditions
Proximal Humerus Fracture
Sponsor
Hannover Medical School
Enrollment
1000
Locations
1
Primary Endpoint
Constant Shoulder Score (CS) (change over time)
Status
Recruiting
Last Updated
9 years ago

Overview

Brief Summary

This register study collects data of patients with proximal humerus and humerus shaft fractures to monitor the healing process by assessing shoulder function and quality of life according to the treatment method (operative or conservative management).

Detailed Description

This prospective data collection of patients with proximal humerus and humerus shaft fractures in a lifelong aftercare treatment plan is for analyzing the healing process in one patient and compared in the whole cohort. According to actual scientific and clinical issues can this data collection be a basis in optimizing the treatment method.

Registry
clinicaltrials.gov
Start Date
June 2016
End Date
June 2025
Last Updated
9 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • patients with trauma-related proximal humerus and humerus shaft fracture
  • cognitively able to fill out a questionaire
  • signed informed consent

Exclusion Criteria

  • patients with oncological-related proximal humerus and humerus shaft fracture
  • cognitively not able to fill out a questionaire
  • no informed consent

Outcomes

Primary Outcomes

Constant Shoulder Score (CS) (change over time)

Time Frame: following a aftercare treatment plan with follow ups after 6,12, 24, 52 weeks in the first year; then through study completion, an average of 1 year

The CS is a commonly used outcome measure for assessing the outcomes of the treatment of shoulder disorders including the pain score, functional assessment, range of motion and strength measures. In week 6, 52 and in the yearly follow ups for comparison reasons the investigators also assess the CS of the not affected shoulder. Reported value is the impaired shoulder-functionality in percent. 100% are equivalent to an unimpaired shoulder function.

DASH (change over time)

Time Frame: following a aftercare treatment plan with follow ups after 1,3,6,12, 24, 52 weeks in the first year; then through study completion, an average of 1 year

The Disabilities of the Arm, Shoulder and Hand (DASH) scoring system was developed to assess the level of disability for any patient with any condition affecting the upper limb by covering domains including symptoms, physical function, social function and psychological function.

Health related quality of life: EuroQoL (EQ-5D-3L+5L) (change over time)

Time Frame: following a aftercare treatment plan with follow ups after 1,3,6,12, 24, 52 weeks in the first year; then through study completion, an average of 1 year

The EQ-5D-3L/5L is a standardized instrument for use as a measure of health outcome. It was designed for self-completion covering mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Furthermore, health state is indicated by a Visual Analog Scale (VAS). EQ-5D assesses the health status of the patients in an one-dimensional number (1-3/1-5).

Subjective Shoulder Value (SSV) (change over time)

Time Frame: following a aftercare treatment plan with follow ups after 1,3,6,12, 24, 52 weeks in the first year; then through study completion, an average of 1 year

The SSV is defined as a patient's subjective shoulder assessment expressed as a percentage of an entirely normal shoulder, which would score 100%.

Secondary Outcomes

  • healing process (change over time)(following a aftercare treatment plan with follow ups after 1, 3, 6,12, 24, 52 weeks in the first year; then through study completion, an average of 1 year)
  • general health conditions(Baseline week 1)

Study Sites (1)

Loading locations...

Similar Trials